The Medicine by Design Global Speaker Series invites established and emerging international leaders in regenerative medicine to engage with our extraordinary community of researchers and clinicians.
Medicine by Design, in partnership with the McEwen Stem Cell Institute, is pleased to welcome Jeffrey Millman, PhD, Assistant Professor of Medicine and Biomedical Engineering, Washington University in St. Louis.
The title of this talk will be, “Engineering Human Islets From Stem Cells For Diabetes Cellular Therapy”
More About Jeffrey Millman:
Professor Jeffrey Millman received his bachelor’s degree from North Carolina State University and PhD in Chemical Engineering from MIT. He completed his post-doctoral training in the laboratory of Dr. Douglas Melton at Harvard University. He was recruited by the Division of Endocrinology, Metabolism and Lipid Research in the Department of Medicine at the Washington University School of Medicine as an Assistant Professor in 2015 and is an affiliated faculty in the Department of Biomedical Engineering.
His current research is focused on synergizing both biomedical engineering and cell biology approaches to use stem cells for the study and treatment of diabetes. He is developing new approaches for the differentiation of insulin-producing islets from stem cells and improving their utility for cell replacement therapy and in vitro disease models. His innovations have been licensed to several biotechnology and startup companies in the diabetes space. His laboratory is supported by the NIH NIDDK and JDRF.
Professor Millman received an American Institute of Chemical Engineering 35 Under 35 Award in 2017, Chemical and Biomolecular Engineering Distinguish Young Alumni Award from North Carolina State University in 2019, and was named a Cellular and Molecular Bioengineering (CMBE) Rising Star by Biomedical Engineering Society in 2021.